New Cancer Center

Chicago's First Freestanding Cancer Center

The 575,000-square-foot facility will provide patients and the community access to the newest diagnostic innovations and leading-edge therapies.

Olatoyosi Odenike, MD, and patient in infusion bay
Providing Unparalleled Cancer Care

As one of only two NCI-designated Comprehensive Cancer Centers in Illinois and the only academic medical center on the city's South Side, UChicago Medicine is uniquely positioned to improve cancer care and outcomes in Chicago and the communities it serves.
view of the South Side from campus, with Center for Care and Discovery in foreground
Strengthening the Health Care Ecosystem

The new cancer facility will add to an emerging ecosystem of health care on the South Side of Chicago, where community hospitals and UChicago Medicine play essential roles in ensuring residents get the right care at the right place at the right time.
construction hard hats lined up on a table
Timeline

UChicago Medicine filed a request in January 2022 to the state regulatory board to spend money on design and site planning for the proposed center. Based on regulatory approval, the facility would open to patients in 2027.
rendering of proposed new freestanding cancer hospital
Cancer Center Facts

UChicago Medicine plans to establish the first freestanding facility dedicated to cancer care and research in Chicago. Here are highlights and other information about the proposed cancer center.

Cancer Patient Stories

Christine Bestvina, MD, lung cancer patient John Polo, and Jessica Donington, MD
Erica Langley, champion body builder and breast cancer survivor
Laura Furmanek had a good response to a new ovarian cancer drug available for a clinical trial
Sharon and Bernie Mark
Cindy and Scott McIntyre. Scott is a CAR T-cell therapy patient
Video placeholder
What Does It Mean to Be an NCI-Designated Comprehensive Cancer Center?

An official comprehensive cancer center designation by the National Cancer Institute (NCI) is the highest federal rating a cancer center can achieve. Learn what's required to earn this designation and how the UChicago Medicine Comprehensive Cancer Center is shaping cancer care and research today and beyond.

Watch Video

Cancer Articles

A digital MRI scan showing lungs. A new study supports saving more lung tissue in lung cancer surgeries.
New study supports saving more lung tissue in lung cancer surgeries
Mid adult woman in isolation at home during COVID-19
Patients with brain and spine cancer suffer more symptoms when unemployed
Akash Patnaik, MD, PhD, is an accomplished physician-scientist and national expert in prostate cancer research
UChicago Medicine-led team selected for the 2022 Michael & Lori Milken Family Foundation-PCF Challenge Award to develop novel immunotherapy approaches in advanced prostate cancer
A 3d illustration of the human urinary system. Newly identified personalized immunotherapy combination treats an aggressive form of advanced prostate cancer
Newly identified personalized immunotherapy combination treats an aggressive form of advanced prostate cancer
UChicago Medicine launches study to improve cancer health equity in clinical trials
UChicago Medicine launches study to improve cancer health equity in clinical trials
UChicago Medicine smoking cessation expert Andrea King, PhD, and Lynn Andrews
After smoking for 54 years, Courage to Quit helps Chicago woman give up cigarettes for good
Rendering of new UChicago Medicine Comprehensive Cancer Center hospital
UChicago Medicine updates plan for the city’s first freestanding cancer facility, following 10 months of community input
Cristian Carpio is a long-time participant in UChicago Medicine Comprehensive Cancer Center
Summer research programs: Creating life-changing experiences for high school and undergraduate students
Researchers have long suspected that interleukin-12 could be a powerful cancer treatment, but it caused dangerous side effects. Now, Pritzker Molecular Engineering researchers have developed a version of the molecule that activates when it reaches a tumor, whereupon it eradicates cancer cells.
‘Masked’ cancer drug sneaks through body to deliver anti-tumor treatment with fewer side effects